文献速递产科母胎医学

使用PAMG-1、胎儿纤连蛋白和phIGFBP-1检测预测有症状孕妇早产:系统综述与Meta分析

Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-09-04

该系统综述与Meta分析检索至2017年10月的文献,纳入报告PAMG-1、fFN和phIGFBP-1预测有早产症状孕妇7天内自发性早产的队列研究。PAMG-1的合并阳性预测值显著高于phIGFBP-1或fFN,其他诊断准确性指标在三项检测间无差异。

要点

  • PAMG-1预测7天内自发性早产的合并阳性预测值为76.3%,显著高于phIGFBP-1的35.2%和fFN的34.1%。
  • PAMG-1、fFN和phIGFBP-1的合并阴性预测值分别为96.6%、93.3%和98.7%。
  • 三项检测的其他诊断准确性指标无差异,PAMG-1的合并阳性似然比为22.51。

核心结论

  • 在有早产症状的孕妇中预测检测后7天内自发性早产时,PAMG-1的阳性预测值显著高于phIGFBP-1或fFN,其他诊断准确性指标在三项检测间无差异。
  • 由于患病率影响诊断试验的预测性能,对自发性早产这种较低患病率的综合征使用高特异性检测可能优化管理。

研究设计与样本

  • 系统综述与Meta分析,检索Cochrane、MEDLINE、PubMed和ResearchGate数据库从建库至2017年10月。
  • 纳入报告PAMG-1、fFN和phIGFBP-1预测有早产症状孕妇7天内自发性早产准确性的队列研究。
  • 采用间接法计算合并效应量,使用双变量线性混合模型对敏感性和特异性的logit进行建模,每个诊断试验作为协变量。

主要发现

  • PAMG-1、fFN和phIGFBP-1预测7天内自发性早产的合并敏感性分别为76%(95%CI 57-89%)、58%(95%CI 47-68%)和93%(95%CI 88-96%)。
  • PAMG-1、fFN和phIGFBP-1的合并特异性分别为97%(95%CI 95-98%)、84%(95%CI 81-87%)和76%(95%CI 70-80%)。
  • PAMG-1、fFN和phIGFBP-1的合并阳性预测值分别为76.3%(95%CI 69-84%,P<0.05)、34.1%(95%CI 29-39%)和35.2%(95%CI 31-40%)。
  • PAMG-1、fFN和phIGFBP-1的合并阴性预测值分别为96.6%(95%CI 94-99%)、93.3%(95%CI 92-95%)和98.7%(95%CI 98-99%)。
  • PAMG-1、fFN和phIGFBP-1的合并阳性似然比分别为22.51(95%CI 15.09-33.60,P<0.05)、3.63(95%CI 2.93-4.50)和3.80(95%CI 3.11-4.66);合并阴性似然比分别为0.24(95%CI 0.12-0.48,P<0.05)、0.50(95%CI 0.39-0.64)和0.09(95%CI 0.05-0.16);ROC曲线下面积分别为0.961、0.874和0.801。

关键数值与推荐

  • PAMG-1预测7天内自发性早产的合并阳性预测值为76.3%(95%CI 69-84%,P<0.05),显著高于phIGFBP-1的35.2%(95%CI 31-40%)和fFN的34.1%(95%CI 29-39%)。
  • PAMG-1的合并阳性似然比为22.51(95%CI 15.09-33.60,P<0.05),fFN为3.63(95%CI 2.93-4.50),phIGFBP-1为3.80(95%CI 3.11-4.66)。
  • PAMG-1的合并阴性似然比为0.24(95%CI 0.12-0.48,P<0.05),fFN为0.50(95%CI 0.39-0.64),phIGFBP-1为0.09(95%CI 0.05-0.16)。

临床怎么用

  • 作者认为,对自发性早产这种较低患病率的综合征使用高特异性检测可能优化管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the accuracy of placental alpha microglobulin-1 (PAMG-1), fetal fibronectin (fFN) and phosphorylated insulin-like growth factor-binding protein-1 (phIGFBP-1) tests in predicting spontaneous preterm birth (sPTB) within 7 days of testing in women with symptoms of preterm labor, through a systematic review and meta-analysis of the literature. The test performance of each biomarker was also assessed according to pretest probability of sPTB ≤ 7 days. METHODS: The Cochrane, MEDLINE, PubMed and ResearchGate bibliographic databases were searched from inception until October 2017. Cohort studies that reported on the predictive accuracy of PAMG-1, fFN and phIGFBP-1 for the prediction of sPTB within 7 days of testing in women with symptoms of preterm labor were included. Summary receiver-operating characteristics (ROC) curves and sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and positive (LR+) and negative (LR-) likelihood ratios were generated using indirect methods for the calculation of pooled effect sizes with a bivariate linear mixed model for the logit of sensitivity and specificity, with each diagnostic test as a covariate, as described by the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. RESULTS: Bivariate mixed model pooled sensitivity of PAMG-1, fFN and phIGFBP-1 for the prediction of sPTB ≤ 7 days was 76% (95% CI, 57-89%), 58% (95% CI, 47-68%) and 93% (95% CI, 88-96%), respectively; pooled specificity was 97% (95% CI, 95-98%), 84% (95% CI, 81-87%) and 76% (95% CI, 70-80%) respectively; pooled PPV was 76.3% (95% CI, 69-84%) (P < 0.05), 34.1% (95% CI, 29-39%) and 35.2% (95% CI, 31-40%), respectively; pooled NPV was 96.6% (95% CI, 94-99%), 93.3% (95% CI, 92-95%) and 98.7% (95% CI, 98-99%), respectively; pooled LR+ was 22.51 (95% CI, 15.09-33.60) (P < 0.05), 3.63 (95% CI, 2.93-4.50) and 3.80 (95% CI, 3.11-4.66), respectively; and pooled LR- was 0.24 (95% CI, 0.12-0.48) (P < 0.05), 0.50 (95% CI, 0.39-0.64) and 0.09 (95% CI, 0.05-0.16), respectively. The areas under the ROC curves for PAMG-1, fFN and phIGFBP-1 for sPTB ≤ 7 days were 0.961, 0.874 and 0.801, respectively. CONCLUSIONS: In the prediction of sPTB within 7 days of testing in women with signs and symptoms of preterm labor, the PPV of PAMG-1 was significantly higher than that of phIGFBP-1 or fFN. Other diagnostic accuracy measures did not differ between the three biomarker tests. As prevalence affects the predictive performance of a diagnostic test, use of a highly specific assay for a lower-prevalence syndrome such as sPTB may optimize management. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Melchor JC, Khalil A, Wing D, et al. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018. PMID: 29920825. doi:10.1002/uog.19119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。